Validation, Commissioning & Design Featured Articles
-
New FDA White Paper Ties Quality To Financial Benefits
8/26/2025
The agency presents as a stepwise approach in which companies can make incremental investments rather than committing large amounts of capital upfront.
-
The High Requirements Placed On Pharmaceutical Labeling Solutions
8/18/2025
Regulators are implementing new rules to combat counterfeit medicines. Learn how serialization, tamper-evident seals, and track-and-trace solutions protect products and patients from risk.
-
Choosing A PCD Configuration For Your Cycle
8/15/2025
Ethylene Oxide (EO) sterilization is essential for medical device safety. Explore how Process Challenge Devices help validate and monitor EO processes with precision across a wide range of applications.
-
Enhancing Ethylene Oxide Sterilization Processes
8/15/2025
PCDs are patented devices designed to meet the demands of EO sterilization. Gain insight into how they support process development, validation, and monitoring with reliable, reproducible performance.
-
How AI Is Revolutionizing Quality Management Systems
8/13/2025
The real question isn't whether pharmaceutical companies should adopt AI in their quality systems, but how to implement it effectively and what specific benefits to expect.
-
Biotech's Plastic Problem Meets Its Match
8/8/2025
Explore how a partnership with UW–Madison and Genentech developed a breakthrough recycling technology that is poised to reshape single-use bioprocessing sustainability.
-
What Happens When You Refuse To Compromise On Sustainability?
8/8/2025
Discover how an empty building shell became a sustainable nanomedicine hub and achieved 47% energy savings and 88% fewer emissions, which sets new standards for innovation in the biologics industry.
-
Redefining Process Design And The Evolution Of Critical Process Parameters
8/6/2025
Effectively managing process parameters and quality attributes is vital for successful drug development. Learn how a Quality by Design approach can optimize your processes and ensure product quality.
-
EMA Issues Revised Annex 11, New Annex 22, And Associated Documents On Data Governance
8/6/2025
The EMA issued three new draft documents in July, all related to the advancement of the use of electronic technology in GMP: AI, computerized systems, and documentation. The public comment period ends Oct. 7.
-
Minimizing The Impact Of Human Errors Using Relational Risk Analysis
8/4/2025
This article describes how a mechanism-based risk analysis approach can provide two complementary opportunities for minimizing the likelihood of a human error impacting pharmaceutical and medical device risks.